Health & Fit: Sanofi pulls Zantac from U.S. and Canada after carcinogen found - Alert: this heartburn medicine would be carcinogenic! - PressFrom - US
  •   
  •   
  •   

Health & Fit Sanofi pulls Zantac from U.S. and Canada after carcinogen found

18:25  18 october  2019
18:25  18 october  2019 Source:   reuters.com

U.S and European regulators reviewing safety of heartburn drugs like Zantac

U.S and European regulators reviewing safety of heartburn drugs like Zantac U.S. and European drug regulators said on Friday they are reviewing the safety of the widely taken heartburn drug ranitidine, commonly known by the brand name Zantac, after they found traces of a probable cancer-causing impurities in some versions of the medicine. © Juanmonino/Getty Images The U.S. Food and Drug Administration said it had found traces of the impurity, called N-nitrosodimethylamine (NDMA), in some versions of drugs with ranitidine in them. Both the FDA and the European Medicines Agency said they will review the drug's safety.

CVS pulls Zantac and its generic brand over possible link to cancer. The popular over-the-counter drug and CVS' own generic brand — ranitidine — will not be carried in the stores moving forward after trace amounts of a known carcinogen were found by health officials.

Zantac is made in Mexico and Sanofi sources its active ingredient from Spain, Koss said. The review of ranitidine comes after Valisure, a New Haven, Connecticut-based online pharmacy that tests all the medications it dispenses, alerted the U . S . Food and Drug Administration that it had detected high

NEW YORK, Oct 18 (Reuters) - Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States and Canada, after the medicines were linked with a probable cancer-causing impurity.

  Sanofi pulls Zantac from U.S. and Canada after carcinogen found © AP Photo/Mark Lennihan

The French drugmaker said it was working with health authorities to determine the level and extent of the recall, which it called a precautionary measure being taken due to possible contamination with a substance called N-nitrosodimethylamine (NDMA).

U.S. and European health regulators said last month they were reviewing the safety of ranitidine, which is commonly sold as Zantac and its generic alternatives, after an online pharmacy called Valisure notified them that it had found impurities in the drugs.

Zantac maker halts heartburn drug's distribution after cancer concerns

Zantac maker halts heartburn drug's distribution after cancer concerns Novartis said it's conducting its own investigation into traces of a potentially cancer-causing ingredient in Zantac

Weeks after the popular heartburn drug ranitidine, known by the brand name Zantac , was Even though the FDA identified the carcinogen , the organization isn’t yet recommending people Sanofi , the company that makes Zantac , is cooperating with the FDA to ensure the drug is safe for consumers.

Published 25 days ago. FDA finds cancer-causing carcinogens in popular heartburn drug Zantac . The U . S . Food and Drug Administration announced Friday that it found a potentially cancer-causing carcinogen in some versions of the popular over-the-counter heartburn medication, Zantac .

The U.S. Food and Drug Administration said earlier this month it found unacceptable levels of NDMA in drugs containing ranitidine. The regulator asked ranitidine makers to conduct their own testing to assess levels of the impurity and to send samples of their products for testing by the agency.

Canada has requested drugmakers halt distribution of the drug while it gathers more information.

Sanofi has sold over-the-counter Zantac in the U.S. and Canada since 2017.

Sanofi CEO Paul Hudson, speaking at a press conference in Framingham, Mass., earlier this week, downplayed concerns about the drug.

"We don't believe there's a risk," Hudson said on Tuesday. "But we have to - and are appropriately duty bound to - satisfy the regulators, which we will do, and we'll move on from there."

Other drugmakers including GlaxoSmithKline and Novartis have recalled or halted distribution of their versions of the drug.

Retailers and pharmacy chains including Walmart Inc CVS Health Corp, Walgreens Boots Alliance Inc and Rite Aid Corp have suspended the sale of over-the-counter heartburn drugs containing ranitidine.

Ranitidine is the latest drug in which cancer-causing impurities have been found. Regulators have been recalling some blood pressure and heart failure medicines since last year. (Reporting by Michael Erman, editing by Louise Heavens)

Potentially dangerous chemical found in heartburn pill Zantac .
CBS News investigation reveals that there might not be just an "impurity" — but something much more serious .© Getty Zantac Your browser does not support this video require(["binding"], function (binding) { binding("wcVideoPlayer", "#video_player_ed1f71ea-285b-4fc8-8db8-093ddf4f02b3").all(); }); At a Connecticut lab, called Valisure, researchers test drugs from its own online pharmacy to check for purity and quality.Last spring, they decided to analyze a few heartburn drugs to see if they contained a chemical called NDMA, a probable carcinogen.

—   Share news in the SOC. Networks

Topical videos:

usr: 1
This is interesting!